Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

PHASE4TerminatedINTERVENTIONAL
Enrollment

1,091

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

November 30, 2008

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus cream 1 %

DRUG

Corticosteroid

conventional corticosteroid-based treatment

Trial Locations (36)

10025

Dermatology Associates of St. Luke's - Roosevelt, New York

12533

Children's Medical Group, Hopewell Junction

15212

Allegheny General Hospital, Pittsburgh

19104

The Childrens' Hospital of Philadelphia, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

23507

Virginia Clinical Research, Norfolk

32503

Emerald Coast Clinical Research, Pensacola

33134

Dermatology Associates and Research, Coral Gables

35209

Alabama Allergy and Asthma Center, Birmingham

37215

Tennessee Clinical Research Center, Nashville

40202

Dermatology Specialists, Louisville

40509

Central Kentucky Research Associates, Lexington

46202

Indiana University Outpatient Clinical Research, Indianapolis

48103

Dermatology, PLLC, Ann Arbor

55905

Mayo Clinic Rochester, Rochester

60614

Children's Memorial Hospital, Chicago

63117

Central Dermatology, St Louis

68144

Skin Specialists, P.C., Omaha

70002

Rx R & D, Metarie

72401

The Children's Clinic of Jonesboro, Jonesboro

72703

Northwest Arkansas Pediatric Clinic, P.A., Fayetteville

77030

Texas Children's Hospital, BCM, Houston

80206

National Jewish Medical and Research Center, Denver

84102

Alpine Medical Group, LLC, Salt Lake City

84120

Granger Medical Clinic, West Valley City

92123

Children's Hospital San Diego, San Diego

92691

Southern California Research, Mission Viejo

92868

Children's Hospital of Orange County, Orange

94063

Stanford Dermatology Clinic and Clinical Trials Dept, Redwood City

94598

Allergy and Asthma Medical Group of Diablo Valley, Inc./ Clinical Research Division, Walnut Creek

95819

Capital Allergy Respiratory Disease Center, Sacramento

97030

Calcagno Research and Development, Gresham

97201

Oregon Health Science University - Dermatology Dept., Portland

98105

Asthma Inc, Seattle

02115

Children's Hospital - Boston, Boston

03756

Dartmouth-Hitchcock Medical Center/Dermatology Section, Lebanon

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY